Clinical Trials
Genfit says FDA has officially cleared the IND to...
GENFIT a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the...
Clinical Trials
Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia...
Spark Therapeutics and Pfizer Inc announced that Lindsey A. George, M.D a hematologist and attending physician at the Children’s Hospital of Philadelphia and lead investigator...
Clinical Trials
Achilles Teutics launched with funds of £13.2 million to...
SYNCONA LLP and CANCER RESEARCH TECHNOLOGY (CRT) announce the formation of Achilles Therapeutics Ltd .The new private company will bring together world-class research from UCL...
Clinical Trials
Thermo Fisher Scientific Expands Global Footprint to Support Cell...
Thermo Fisher Scientific, the world leader in serving science announced the expansion of its Fisher BioServices cryogenic service capabilities in Japan. This...
Clinical Trials
Sun Pharma announces the Phase 3 results of investigational...
Sun Pharma has announced late-breaking data from two pivotal Phase-3 clinical trials (reSURFACE 1 and 2) achieving the primary endpoint with tildrakizumab, an investigational IL-23p19...
Clinical Trials
AbbVie’s Investigational HCV Regimen Receives U.S. FDA Breakthrough Therapy...
AbbVie a global biopharmaceutical company announced that the U.S. FDA has granted Breakthrough Therapy Designation (BTD) for the investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530)...
Clinical Trials
Genocea’s Immunotherapy GEN-003 Demonstrates Significant Reduction of Viral Shedding...
Genocea Biosciences, a biopharmaceutical company developing T cell-directed vaccines and immunotherapies announced positive results from its ongoing Phase 2b trial evaluating a new Phase 3-ready...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.